Free Trial

Intelligent Bio Solutions Q2 2024 Earnings Report

Intelligent Bio Solutions logo
$2.20 +0.10 (+4.90%)
As of 02/21/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Intelligent Bio Solutions EPS Results

Actual EPS
-$2.07
Consensus EPS
-$3.24
Beat/Miss
Beat by +$1.17
One Year Ago EPS
N/A

Intelligent Bio Solutions Revenue Results

Actual Revenue
$0.76 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Intelligent Bio Solutions Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Intelligent Bio Solutions Earnings Headlines

Intelligent Bio Solutions prices 1.3M shares at $2.00 in public offering
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
Intelligent Bio Solutions files to sell common stock, no amount given
See More Intelligent Bio Solutions Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Intelligent Bio Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intelligent Bio Solutions and other key companies, straight to your email.

About Intelligent Bio Solutions

Intelligent Bio Solutions (NASDAQ:INBS), a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

View Intelligent Bio Solutions Profile

More Earnings Resources from MarketBeat